Correlation between mimecan expression and coronary artery stenosis in patients with coronary heart disease

Objective: This study aimed to investigate the correlation between coronary artery stenosis and Mimecan expression in patients with coronary heart disease (CHD). Methods: Seventy eight patients with CHD and 80 controls without vascular lesions were recruited into present study. CHD patients were divided into one-vessel CHD subgroup, 2-vessel CHD subgroup and multivessel CHD subgroup. ELISA was performed to detect the expressions of serum Mimecan and nuclear factor kappaB (NF-kappa B). Results: When compared with control group, the expressions of serum mimecan gene and NF-kappa B significantly increased in CHD groups (P < 0.05); When compared with one-vessel and two-vessel CHD subgroups, the expressions of serum mimecan and NF-kappa B significantly increased in multivessel CHD subgroup (P < 0.05), significant difference was observed among three subgroups (P < 0.05). The expressions of serum mimecan and NF-kappa B were positively related to the severity of coronary lesions (r(mimecan) = 0.79, r(NF-kappa B) = 0.83, P < 0.05). Conclusion: Increased expressions of serum mimecan and NF-kappa B in CHD patients are related to cardiac insufficiency, which may be ascribed to the binding of NF-kappa B to mimecan gene.